It helped to pioneer cardiovascular interventional devices in China, and was a model for medical technology collaboration between Hong Kong and the Chinese mainland. Now, 22-year-old Chinese medical device maker OrbusNeich Medical Group Holdings Ltd. wants to move to another new frontier with plans for a Hong Kong IPO.
作者陈嘉仪，本文仅代表个人观点
您已阅读4%（335字），剩余96%（8284字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。